373 related articles for article (PubMed ID: 20510347)
1. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
[TBL] [Abstract][Full Text] [Related]
2. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT.
Sakaguchi H; Ashikaga T; Miyazawa M; Yoshida Y; Ito Y; Yoneyama K; Hirota M; Itagaki H; Toyoda H; Suzuki H
Toxicol In Vitro; 2006 Aug; 20(5):774-84. PubMed ID: 16337770
[TBL] [Abstract][Full Text] [Related]
3. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).
Sakaguchi H; Ashikaga T; Miyazawa M; Kosaka N; Ito Y; Yoneyama K; Sono S; Itagaki H; Toyoda H; Suzuki H
Cell Biol Toxicol; 2009 Apr; 25(2):109-26. PubMed ID: 18204907
[TBL] [Abstract][Full Text] [Related]
4. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
[TBL] [Abstract][Full Text] [Related]
5. Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
An S; Kim S; Huh Y; Lee TR; Kim HK; Park KL; Eun HC
Contact Dermatitis; 2009 Apr; 60(4):185-92. PubMed ID: 19338585
[TBL] [Abstract][Full Text] [Related]
6. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT).
Nukada Y; Ashikaga T; Sakaguchi H; Sono S; Mugita N; Hirota M; Miyazawa M; Ito Y; Sasa H; Nishiyama N
Contact Dermatitis; 2011 Dec; 65(6):343-53. PubMed ID: 21767275
[TBL] [Abstract][Full Text] [Related]
7. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol.
Ashikaga T; Yoshida Y; Hirota M; Yoneyama K; Itagaki H; Sakaguchi H; Miyazawa M; Ito Y; Suzuki H; Toyoda H
Toxicol In Vitro; 2006 Aug; 20(5):767-73. PubMed ID: 16311011
[TBL] [Abstract][Full Text] [Related]
8. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1.
Sakaguchi H; Miyazawa M; Yoshida Y; Ito Y; Suzuki H
Arch Dermatol Res; 2007 Feb; 298(9):427-37. PubMed ID: 17119987
[TBL] [Abstract][Full Text] [Related]
9. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
[TBL] [Abstract][Full Text] [Related]
10. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program.
Aeby P; Ashikaga T; Bessou-Touya S; Schepky A; Gerberick F; Kern P; Marrec-Fairley M; Maxwell G; Ovigne JM; Sakaguchi H; Reisinger K; Tailhardat M; Martinozzi-Teissier S; Winkler P
Toxicol In Vitro; 2010 Sep; 24(6):1465-73. PubMed ID: 20624454
[TBL] [Abstract][Full Text] [Related]
11. The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories.
Andreas N; Caroline B; Leslie F; Frank G; Kimberly N; Allison H; Heather I; Robert L; Stefan O; Hendrik R; Andreas S; Roger E
Toxicol In Vitro; 2011 Apr; 25(3):733-44. PubMed ID: 21195160
[TBL] [Abstract][Full Text] [Related]
12. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
[TBL] [Abstract][Full Text] [Related]
13. In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells.
Reuter H; Spieker J; Gerlach S; Engels U; Pape W; Kolbe L; Schmucker R; Wenck H; Diembeck W; Wittern KP; Reisinger K; Schepky AG
Toxicol In Vitro; 2011 Feb; 25(1):315-23. PubMed ID: 20932890
[TBL] [Abstract][Full Text] [Related]
14. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between keratinocytes and dendritic cells: impact on the prediction of sensitization.
Hennen J; Aeby P; Goebel C; Schettgen T; Oberli A; Kalmes M; Blömeke B
Toxicol Sci; 2011 Oct; 123(2):501-10. PubMed ID: 21742781
[TBL] [Abstract][Full Text] [Related]
16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
17. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
18. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
19. Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals.
Nukada Y; Miyazawa M; Kazutoshi S; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Mar; 27(2):609-18. PubMed ID: 23149339
[TBL] [Abstract][Full Text] [Related]
20. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
